AI Stock Analysis - Intuitive Surgical (ISRG)
Analysis generated October 10, 2025.
Intuitive Surgical, Inc. is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Known for its innovative Da Vinci Surgical Systems, the company has transformed the field of surgery by developing products that enable surgeons to perform complex procedures with minimal invasiveness, which in turn enhances patient outcomes. With a technological edge and a strong market position, Intuitive Surgical remains a cornerstone in the robotics-assisted surgery industry. The company continues to push the innovation envelope, aiming to expand the capabilities and reach of its surgical systems.
Stock Alerts - Intuitive Surgical (ISRG)
![]() |
Intuitive Surgical | January 13 Gilbert Cisneros (member of U.S. congress) is buying shares |
![]() |
Intuitive Surgical | December 16 Insider Alert: Brosius Mark is selling shares |
![]() |
Intuitive Surgical | December 16 Gilbert Cisneros (member of U.S. congress) is buying shares |
![]() |
Intuitive Surgical | December 11 Insider Alert: Curet Myriam is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Intuitive Surgical
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Job Posts | 492 | Sign up | Sign up | Sign up | |
| Sentiment | 85 | Sign up | Sign up | Sign up | |
| Webpage traffic | 10,000 | Sign up | Sign up | Sign up | |
| Employee Rating | 84 | Sign up | Sign up | Sign up | |
| Google Trends | N/A | Sign up | Sign up | Sign up | |
| Patents | N/A | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Facebook Engagement | 365 | Sign up | Sign up | Sign up | |
| Facebook Followers | 7,770 | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | 123 | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 20,017 | Sign up | Sign up | Sign up | |
| X Followers | 16,842 | Sign up | Sign up | Sign up | |
| X Mentions | 67 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up | |
| ESG | N/A | Sign up | Sign up | Sign up | |
| Lobbying Cost | $67,000 | Sign up | Sign up | Sign up | |
| Business Outlook | 86 | Sign up | Sign up | Sign up | |
| Linkedin Employees | 12,295 | Sign up | Sign up | Sign up |
About Intuitive Surgical
Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.
| Price | $525.04 |
| Target Price | Sign up |
| Volume | 1,480,000 |
| Market Cap | $188B |
| Year Range | $429.59 - $592.85 |
| Dividend Yield | 0% |
| PE Ratio | 66.67 |
| Analyst Rating | 76% buy |
| Industry | Medical Devices |
In the news
![]() |
Intuitive Surgical just upgraded at Freedom Capital, here's whyJanuary 26 - Thefly.com |
![]() |
China Remains Competitive: Can ISRG Defend Share Amid Local Rivals?January 25 - Yahoo |
![]() |
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to KnowJanuary 25 - Yahoo |
![]() |
3 Troubling Trends for Intuitive Surgical – and 1 Bright SpotJanuary 23 - Yahoo |
![]() |
Intuitive Surgical price target raised by $10 at Piper Sandler, here's whyJanuary 23 - Thefly.com |
![]() |
Intuitive Surgical price target lowered by $45 at Citi, here's whyJanuary 23 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 2.87B | 959M | 1.91B | 795M | 956M | 2.530 |
| Q3 '25 | 2.51B | 843M | 1.66B | 704M | 1.02B | 2.400 |
| Q2 '25 | 2.44B | 819M | 1.62B | 658M | 987M | 2.190 |
| Q1 '25 | 2.25B | 796M | 1.46B | 698M | 719M | 1.810 |
| Q4 '24 | 2.41B | 771M | 1.64B | 686M | 860M | 2.210 |
Insider Transactions View All
| Brosius Mark filed to sell 443 shares at $548.5. December 15 '25 |
| Brosius Mark filed to sell 131 shares at $548.5. December 17 '25 |
| Brosius Mark filed to sell 907 shares at $547.4. December 15 '25 |
| Brosius Mark filed to sell 595 shares at $547.4. December 17 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Jan 13, 26 | Buy | $1K - $15K |
| Gilbert Cisneros |
Dec 16, 25 | Buy | $1K - $15K |
| Josh Gottheimer |
Oct 16, 25 | Sell | $1K - $15K |
Read more about Intuitive Surgical (ISRG) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Intuitive Surgical
The Market Cap of Intuitive Surgical is $188B.
As of today, Intuitive Surgical's PE (Price to Earnings) ratio is 66.67.
Currently, the price of one share of Intuitive Surgical stock is $525.04.
The ISRG stock price chart above provides a comprehensive visual representation of Intuitive Surgical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Intuitive Surgical shares. Our platform offers an up-to-date ISRG stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Intuitive Surgical (ISRG) does not offer dividends to its shareholders. Investors interested in Intuitive Surgical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Intuitive Surgical are Boston Scientific, Edwards Lifesciences, Medtronic, Stryker, and Becton Dickinson and Co.







